Clinical Trial

Interest of Hypnosis When Setting up Non-invasive Ventilation in a Conscious Patient With COPD and/or Obesity With a BMI Greater Than 30, Suffering Fromacute Respiratory Distress in Adult Intensive Care

Study acronym: HYVIR
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 24, 2025 (before its estimated November 20, 2025 completion). Its status may not reflect the trial's current state.
Summary
Discomfort during respiratory decompensation of a patient with chronic obstructive pulmonary disease (COPD) and/or obesity with a BMI greater than 30, in intensive care and the establishment of non-invasive ventilation (NIV) is frequent and a source of failure. this therapy. Pharmacological treatments may be impossible due to the pathology, the risk of it worsening and adverse effects. In this context, hypnosis appears to be a tool that would promote comfort and thus increase tolerance of NIV.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2020-01-06; most recent amendment 2025-06-20.
Status change: Not Yet Recruiting → Recruiting 2022-11-08
Trial Details
NCT Number NCT04220463
Lead Sponsor Rennes University Hospital
Conditions Chronic Obstructive Pulmonary Disease (COPD), Obesity With a BMI Greater Than 30, Acute Respiratory Distress in Adult Intensive Care
Enrollment 50 participants
Start Date 2021-11-20
Primary Completion 2025-11-20 (estimated)
Study Completion 2025-11-20 (estimated)
Updated on ClinicalTrials.gov 2025-06-24